AKUMS.NS
AKUMS.NS
INE09XN01023
AKUMS DRUGS AND PHARMA L
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 42.513.080.000 40.710.930.000
4.4%
Cost of Revenue 25.482.100.000 24.657.370.000
3.3%
Gross Profit 17.030.980.000 16.053.560.000
6.1%
13.291.270.000 12.947.050.000
2.7%
Operating Income 3.739.710.000 3.106.510.000
20.4%
Pretax Income 3.821.010.000 3.452.530.000
10.7%
Net Income Common Stockholders 2.551.880.000 3.381.760.000
24.5%
-- --
--
-- --
--
ende